|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/65 |
| (11) | Patento numeris | 2935319 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13824203.7 |
| Europos patento paraiškos padavimo data | 2013-12-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/060982 |
| Data | 2013-12-16 |
| (87) | Numeris | WO 2014/097113 |
| Data | 2014-06-26 |
| (30) | Numeris | Data | Šalis |
| 201261738466 P | 2012-12-18 | US |
| (72) |
Fornaro, Mara, CH
Glass, David, US
Jostock, Thomas, CH
Laux, Holger, CH
Romand, Sandrine, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PRODUCTION OF THERAPEUTIC PROTEINS IN GENETICALLY MODIFIED MAMMALIAN CELLS |
| PRODUCTION OF THERAPEUTIC PROTEINS IN GENETICALLY MODIFIED MAMMALIAN CELLS |